Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Selective Inhibition of ADAM17 Efficiently Mediates Glycoprotein Ibα Retention During Ex Vivo Generation of Human Induced Pluripotent Stem Cell-Derived Platelets
Shinji Hirata, Tatsunori Murata, Daisuke Suzuki, et al.
Stem Cells Translational Medicine (2016) Vol. 6, Iss. 3, pp. 720-730
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Turbulence Activates Platelet Biogenesis to Enable Clinical Scale Ex Vivo Production
Yukitaka Ito, Sou Nakamura, Naoshi Sugimoto, et al.
Cell (2018) Vol. 174, Iss. 3, pp. 636-648.e18
Open Access | Times Cited: 242
Recent Advances in ADAM17 Research: A Promising Target for Cancer and Inflammation
Marcia L. Moss, Dmitriy Minond
Mediators of Inflammation (2017) Vol. 2017, pp. 1-21
Open Access | Times Cited: 133
Strategies to Target ADAM17 in Disease: From Its Discovery to the iRhom Revolution
Matteo Calligaris, Doretta Cuffaro, Simone Bonelli, et al.
Molecules (2021) Vol. 26, Iss. 4, pp. 944-944
Open Access | Times Cited: 85
iPLAT1: the first-in-human clinical trial of iPSC-derived platelets as a phase 1 autologous transfusion study
Naoshi Sugimoto, Junya Kanda, Sou Nakamura, et al.
Blood (2022) Vol. 140, Iss. 22, pp. 2398-2402
Open Access | Times Cited: 53
ADAM17: An Emerging Therapeutic Target for Lung Cancer
Mohamed I. Saad, Stefan Rose‐John, Brendan J. Jenkins
Cancers (2019) Vol. 11, Iss. 9, pp. 1218-1218
Open Access | Times Cited: 67
iPSC-Derived Platelets Depleted of HLA Class I Are Inert to Anti-HLA Class I and Natural Killer Cell Immunity
Daisuke Suzuki, Charlotte Flahou, Norihide Yoshikawa, et al.
Stem Cell Reports (2019) Vol. 14, Iss. 1, pp. 49-59
Open Access | Times Cited: 63
Platelet production from induced pluripotent stem cells
Naoshi Sugimoto, Koji Eto
Journal of Thrombosis and Haemostasis (2017) Vol. 15, Iss. 9, pp. 1717-1727
Open Access | Times Cited: 54
Immunomodulatory role of metalloproteinase ADAM17 in tumor development
Kai Wang, Zixue Xuan, Xiaoyan Liu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 26
EZH2 mutations and impact on clinical outcome: an analysis in 1,604 patients with newly diagnosed acute myeloid leukemia
Sebastian Stasik, Jan Moritz Middeke, Michael Krämer, et al.
Haematologica (2019) Vol. 105, Iss. 5, pp. e228-e231
Open Access | Times Cited: 42
Human‐induced pluripotent stem cell‐derived blood products: state of the art and future directions
Marten Hansen, Marieke von Lindern, Emile van den Akker, et al.
FEBS Letters (2019) Vol. 593, Iss. 23, pp. 3288-3303
Open Access | Times Cited: 41
Induced Pluripotent Stem Cell-Derived Red Blood Cells and Platelet Concentrates: From Bench to Bedside
Daniele Focosi, Giovanni Amabile
Cells (2017) Vol. 7, Iss. 1, pp. 2-2
Open Access | Times Cited: 40
Renal ADAM10 and 17: Their Physiological and Medical Meanings
Takashi Kato, Man Hagiyama, Akihiko Ito
Frontiers in Cell and Developmental Biology (2018) Vol. 6
Open Access | Times Cited: 38
Production and nonclinical evaluation of an autologous iPSC–derived platelet product for the iPLAT1 clinical trial
Naoshi Sugimoto, Sou Nakamura, Shin Shimizu, et al.
Blood Advances (2022) Vol. 6, Iss. 23, pp. 6056-6069
Open Access | Times Cited: 22
Uniform impact on individual megakaryocytes is essential for efficient in vitro platelet production
Andrei K. Garzon Dasgupta, Anaïs Pongérard, Léa Mallo, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Identifying and enriching platelet-producing human stem cell–derived megakaryocytes using factor V uptake
Xiuli Sim, Danuta Jarocha, Vincent Hayes, et al.
Blood (2017) Vol. 130, Iss. 2, pp. 192-204
Open Access | Times Cited: 34
GPIbα shedding in platelets is controlled by strict intracellular containment of both enzyme and substrate
Katrijn R. Six, Caitlin Debaene, Michelle Van den Hauwe, et al.
Journal of Thrombosis and Haemostasis (2023) Vol. 21, Iss. 8, pp. 2223-2235
Open Access | Times Cited: 9
Induced Pluripotent Stem Cell–Derived Megakaryocytes and Platelets for Disease Modeling and Future Clinical Applications
Sara Borst, Xiuli Sim, Mortimer Poncz, et al.
Arteriosclerosis Thrombosis and Vascular Biology (2017) Vol. 37, Iss. 11, pp. 2007-2013
Open Access | Times Cited: 30
Recent developments and strategies for the discovery of TACE inhibitors
Prashant R. Murumkar, Rahul B. Ghuge, Monica Chauhan, et al.
Expert Opinion on Drug Discovery (2020) Vol. 15, Iss. 7, pp. 779-801
Closed Access | Times Cited: 27
Generation and manipulation of human iPSC-derived platelets
Naoshi Sugimoto, Koji Eto
Cellular and Molecular Life Sciences (2021) Vol. 78, Iss. 7, pp. 3385-3401
Open Access | Times Cited: 19
Photoaffinity labeling coupled with proteomics identify PDI-ADAM17 module is targeted by (−)-vinigrol to induce TNFR1 shedding and ameliorate rheumatoid arthritis in mice
Yinhua Zhu, Lu Wang, Jing Li, et al.
Cell chemical biology (2023) Vol. 31, Iss. 3, pp. 452-464.e10
Closed Access | Times Cited: 7
The Gut-Brain Axis in Autism Spectrum Disorder: A Focus on the Metalloproteases ADAM10 and ADAM17
Yuanpeng Zheng, Tessa A. Verhoeff, Paula Perez‐Pardo, et al.
International Journal of Molecular Sciences (2020) Vol. 22, Iss. 1, pp. 118-118
Open Access | Times Cited: 20
Blood products are used to treat a multitude of diseases, so the blood transfusion system needs to be enhanced. CRISPR/Cas9 has made it viable to make HLA class I-deleted blood products to avoid rejection
Moataz Dowaidar
(2021)
Closed Access | Times Cited: 15
A New Inhibitor of ADAM17 Composed of a Zinc-Binding Dithiol Moiety and a Specificity Pocket-Binding Appendage
Hiroshi Tateishi, M Tateishi, Mohamed O. Radwan, et al.
Chemical and Pharmaceutical Bulletin (2021) Vol. 69, Iss. 11, pp. 1123-1130
Open Access | Times Cited: 14
Effect of miR-26a-5p targeting ADAM17 gene on apoptosis, inflammatory factors and oxidative stress response of myocardial cells in hypoxic model
Wen Xia, Ying Yin, Xiaohong Li, et al.
Journal of Bioenergetics and Biomembranes (2020) Vol. 52, Iss. 2, pp. 83-92
Closed Access | Times Cited: 14
The Glycoprotein Ib-IX-V Complex
Renhao Li
Platelets (2019), pp. 193-211
Closed Access | Times Cited: 13
Page 1 - Next Page

Scroll to top